StageZero Life Sciences Ltd (SZLS) — Strategic Asset Allocation Index
StageZero Life Sciences Ltd (SZLS) has a Strategic Asset Allocation Index of 38.8% as of September 2022. Strategic assets (PP&E of CA$560.20K plus long-term investments of CA$-) total CA$560.20K, measured against net assets of CA$1.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
StageZero Life Sciences Ltd Strategic Asset Allocation Index (2021–2021)
This chart shows how StageZero Life Sciences Ltd's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the index stands at 38.8%, representing strategic assets of CA$560.20K against net assets of CA$1.44 Million CAD. Explore StageZero Life Sciences Ltd (SZLS) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for StageZero Life Sciences Ltd (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for StageZero Life Sciences Ltd from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of StageZero Life Sciences Ltd.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 31.6% | CA$871.89K | CA$871.89K | CA$- | CA$2.76 Million | — |